Abstract
Beside blood-borne circulating miRNAs, miRNAs have been identified in other body fluid and excrements including stool, bile, saliva, and urine. Given the direct link of these body fluids to certain organs, their analysis for potential diagnostic miRNA markers is plausible. Several independent findings underline the potential utility of stool-derived miRNAs in the diagnosis of colorectal and pancreatic cancer. Given the difficulties in the diagnosis of cholangiocellular cancer, biliary miRNAs might be envisaged as useful markers. Several miRNAs have been identified in the saliva that could be associated with diseases, including tumors of the oral cavity. The urinary pool of miRNAs could be exploited for the diagnosis of urinary tract diseases and some appear to enable early diagnosis. In this chapter, we present findings supporting the potential diagnostic utility of fecal, biliary, salivary, and urinary miRNAs focusing mostly on tumors.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Abu-Hamda EM, Baron TH (2004) Endoscopic management of cholangiocarcinoma. Semin Liver Dis 24(2):165–175. doi:10.1055/s-2004-828893
Aslam MI, Taylor K, Pringle JH, Jameson JS (2009) MicroRNAs are novel biomarkers of colorectal cancer. Br J Surg 96:702–710
Bacon S, Engelbrecht B, Schmid J et al (2015) MicroRNA-224 is readily detectable in urine of individuals with diabetes mellitus and is a potential indicator of beta-cell demise. Genes 6:399–416
Barutta F, Tricarico M, Corbelli A et al (2013) Urinary exosomal microRNAs in incipient diabetic nephropathy. PLoS ONE 8, e73798
Cote GA, Gore AJ, McElyea SD et al (2014) A pilot study to develop a diagnostic test for pancreatic ductal adenocarcinoma based on differential expression of select miRNA in plasma and bile. Am J Gastroenterol 109:1942–1952
Erbes T, Hirschfeld M, Rucker G et al (2015) Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker. BMC Cancer 15:193
Gallo A, Alevizos I (2013) Isolation of circulating microRNA in saliva. Methods Mol Biol 1024:183–190
Ghaneh P, Costello E, Neoptolemos JP (2008) Biology and management of pancreatic cancer. Postgrad Med J 84:478–497
Haug U, Wente MN, Seiler CM et al (2008) Stool testing for the early detection of pancreatic cancer: rationale and current evidence. Expert Rev Mol Diagn 8:753–759
He Q, Cai L, Shuai L et al (2013) Ars2 is overexpressed in human cholangiocarcinomas and its depletion increases PTEN and PDCD4 by decreasing microRNA-21. Mol Carcinog 52:286–296
Ichii O, Otsuka S, Sasaki N et al (2012) Altered expression of microRNA miR-146a correlates with the development of chronic renal inflammation. Kidney Int 81:280–292
Ichii O, Otsuka-Kanazawa S, Horino T et al (2014) Decreased miR-26a expression correlates with the progression of podocyte injury in autoimmune glomerulonephritis. PLoS ONE 9, e110383
Jarnagin WR, Shoup M (2004) Surgical management of cholangiocarcinoma. Semin Liv Dis 24:189–199
Khan SA, Thomas HC, Davidson BR et al (2005) Cholangiocarcinoma. Lancet 366:1303–1314
Kishimoto T, Eguchi H, Nagano H et al (2013) Plasma miR-21 is a novel diagnostic biomarker for biliary tract cancer. Cancer Sci 104:1626–1631
Korzeniewski N, Tosev G, Pahernik S et al (2015) Identification of cell-free microRNAs in the urine of patients with prostate cancer. Urol Oncol 33:16.e17–22
Link A, Balaguer F, Shen Y et al (2010) Fecal MicroRNAs as novel biomarkers for colon cancer screening. Cancer Epidemiol Biomarkers Prev 19:1766–1774
Link A, Becker V, Goel A et al (2012) Feasibility of fecal microRNAs as novel biomarkers for pancreatic cancer. PLoS ONE 7, e42933
Liu CJ, Lin SC, Yang CC et al (2012) Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma. Head Neck 34:219–224
Lv LL, Cao YH, Ni HF et al (2013) MicroRNA-29c in urinary exosome/microvesicle as a biomarker of renal fibrosis. Am J Physiol Ren Physiol 305:F1220–F1227
Lv Y, Qi R, Xu J et al (2014) Profiling of serum and urinary microRNAs in children with atopic dermatitis. PLoS ONE 9, e115448
Matse JH, Yoshizawa J, Wang X et al (2013) Discovery and prevalidation of salivary extracellular microRNA biomarkers panel for the noninvasive detection of benign and malignant parotid gland tumors. Clin Cancer Res 19:3032–3038
Mlcochova H, Hezova R, Stanik M et al (2014) Urine microRNAs as potential noninvasive biomarkers in urologic cancers. Urol Oncol 32:41.e41–49
Momen-Heravi F, Trachtenberg AJ, Kuo WP et al (2014) Genomewide study of salivary microRNAs for detection of oral cancer. J Dent Res 93:86s–93s
Nassirpour R, Mathur S, Gosink MM et al (2014) Identification of tubular injury microRNA biomarkers in urine: comparison of next-generation sequencing and qPCR-based profiling platforms. BMC Genomics 15:485
Nehls O, Gregor M, Klump B (2004) Serum and bile markers for cholangiocarcinoma. Semin Liv Dis 24:139–154
Osipova J, Fischer DC, Dangwal S et al (2014) Diabetes-associated microRNAs in pediatric patients with type 1 diabetes mellitus: a cross-sectional cohort study. J Clin Endocrinol Metab 99:E1661–E1665
Papadopoulos T, Belliere J, Bascands JL et al (2015) miRNAs in urine: a mirror image of kidney disease? Expert Rev Mol Diagn 15:361–374
Park NJ, Zhou H, Elashoff D et al (2009) Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res 15:5473–5477
Ramachandran K, Saikumar J, Bijol V et al (2013) Human miRNome profiling identifies microRNAs differentially present in the urine after kidney injury. Clin Chem 59:1742–1752
Ramezani A, Devaney JM, Cohen S et al (2015) Circulating and urinary microRNA profile in focal segmental glomerulosclerosis: a pilot study. Eur J Clin Invest 45:394–404
Rotelli MT, Di Lena M, Cavallini A et al (2015) Fecal microRNA profile in patients with colorectal carcinoma before and after curative surgery. Int J Colorectal Dis 30:891–898
Salazar C, Nagadia R, Pandit P et al (2014) A novel saliva-based microRNA biomarker panel to detect head and neck cancers. Cell Oncol 37:331–338
Shigehara K, Yokomuro S, Ishibashi O et al (2011) Real-time PCR-based analysis of the human bile microRNAome identifies miR-9 as a potential diagnostic biomarker for biliary tract cancer. PLoS ONE 6, e23584
Srivastava A, Goldberger H, Dimtchev A et al (2013) MicroRNA profiling in prostate cancer--the diagnostic potential of urinary miR-205 and miR-214. PLoS ONE 8, e76994
von Brandenstein M, Pandarakalam JJ, Kroon L et al (2012) MicroRNA 15a, inversely correlated to PKCalpha, is a potential marker to differentiate between benign and malignant renal tumors in biopsy and urine samples. Am J Pathol 180:1787–1797
Wang G, Kwan BC, Lai FM et al (2011) Elevated levels of miR-146a and miR-155 in kidney biopsy and urine from patients with IgA nephropathy. Dis Markers 30:171–179
Wang G, Tam LS, Kwan BC et al (2012) Expression of miR-146a and miR-155 in the urinary sediment of systemic lupus erythematosus. Clin Rheumatol 31:435–440
Weber JA, Baxter DH, Zhang S et al (2010) The microRNA spectrum in 12 body fluids. Clin Chem 56:1733–1741
Wu CW, Ng SS, Dong YJ et al (2012) Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps. Gut 61:739–745
Wu CW, Ng SC, Dong Y et al (2014) Identification of microRNA-135b in stool as a potential noninvasive biomarker for colorectal cancer and adenoma. Clin Cancer Res 20:2994–3002
Xie ZJ, Chen G, Zhang XC et al (2012) Saliva supernatant miR-21: a novel potential biomarker for esophageal cancer detection. Asian Pac J Cancer Prev 13:6145–6149
Xie Z, Chen G, Zhang X et al (2013) Salivary microRNAs as promising biomarkers for detection of esophageal cancer. PLoS ONE 8, e57502
Yang Y, Li YX, Yang X et al (2013) Progress risk assessment of oral premalignant lesions with saliva miRNA analysis. BMC Cancer 13:129
Yang JY, Sun YW, Liu DJ et al (2014) MicroRNAs in stool samples as potential screening biomarkers for pancreatic ductal adenocarcinoma cancer. Am J Cancer Res 4:663–673
Yau TO, Wu CW, Dong Y et al (2014) microRNA-221 and microRNA-18a identification in stool as potential biomarkers for the non-invasive diagnosis of colorectal carcinoma. Br J Cancer 111:1765–1771
Zahran F, Ghalwash D, Shaker O et al (2015) Salivary microRNAs in oral cancer. Oral Dis. doi:10.1111/odi.12340 [Epub ahead of print]
Zhang DZ, Lau KM, Chan ES et al (2014a) Cell-free urinary microRNA-99a and microRNA-125b are diagnostic markers for the non-invasive screening of bladder cancer. PLoS ONE 9, e100793
Zhang W, Zhang C, Chen H et al (2014b) Evaluation of microRNAs miR-196a, miR-30a-5P, and miR-490 as biomarkers of disease activity among patients with FSGS. Clin J Am Soc Nephrol 9:1545–1552
Zhong XY, Yu JH, Zhang WG et al (2012) MicroRNA-421 functions as an oncogenic miRNA in biliary tract cancer through down-regulating farnesoid X receptor expression. Gene 493:44–51
Zhou X, Zhang X, Yang Y et al (2014) Urinary cell-free microRNA-106b as a novel biomarker for detection of bladder cancer. Med Oncol 31:197
Zhou J, Gong G, Tan H et al (2015) Urinary microRNA-30a-5p is a potential biomarker for ovarian serous adenocarcinoma. Oncol Rep 33:2915–2923
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Igaz, I., Igaz, P. (2015). Diagnostic Relevance of microRNAs in Other Body Fluids Including Urine, Feces, and Saliva. In: Igaz, P. (eds) Circulating microRNAs in Disease Diagnostics and their Potential Biological Relevance. Experientia Supplementum, vol 106. Springer, Basel. https://doi.org/10.1007/978-3-0348-0955-9_11
Download citation
DOI: https://doi.org/10.1007/978-3-0348-0955-9_11
Published:
Publisher Name: Springer, Basel
Print ISBN: 978-3-0348-0953-5
Online ISBN: 978-3-0348-0955-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)